149 related articles for article (PubMed ID: 31199986)
1. SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer.
Wu X; Xin Z; Zou Z; Lu C; Yu Z; Feng S; Pan P; Hao G; Dong Y; Yang Y
Semin Cancer Biol; 2020 Dec; 67(Pt 1):114-121. PubMed ID: 31199986
[TBL] [Abstract][Full Text] [Related]
2. SOX4: Epigenetic regulation and role in tumorigenesis.
Hanieh H; Ahmed EA; Vishnubalaji R; Alajez NM
Semin Cancer Biol; 2020 Dec; 67(Pt 1):91-104. PubMed ID: 31271889
[TBL] [Abstract][Full Text] [Related]
3. SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?
Lourenço AR; Coffer PJ
Trends Cancer; 2017 Aug; 3(8):571-582. PubMed ID: 28780934
[TBL] [Abstract][Full Text] [Related]
4. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
[TBL] [Abstract][Full Text] [Related]
5. ETS1 promoted cell growth, metastasis and epithelial-mesenchymal transition process in melanoma by regulating miR-16-mediated SOX4 expression.
Yang LX; Guo HB; Liu SY; Feng HP; Shi J
Melanoma Res; 2021 Aug; 31(4):298-308. PubMed ID: 34039939
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition.
Ruan H; Yang H; Wei H; Xiao W; Lou N; Qiu B; Xu G; Song Z; Xiao H; Liu L; Zhou Y; Hu W; Chen K; Chen X; Zhang X
Int J Oncol; 2017 Jul; 51(1):336-346. PubMed ID: 28534986
[TBL] [Abstract][Full Text] [Related]
7. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
[TBL] [Abstract][Full Text] [Related]
8. Forkhead box O proteins: Crucial regulators of cancer EMT.
Ma Z; Xin Z; Hu W; Jiang S; Yang Z; Yan X; Li X; Yang Y; Chen F
Semin Cancer Biol; 2018 Jun; 50():21-31. PubMed ID: 29427645
[TBL] [Abstract][Full Text] [Related]
9. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
[TBL] [Abstract][Full Text] [Related]
11. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
Liu Y; Zeng S; Jiang X; Lai D; Su Z
Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop.
Li D; He C; Wang J; Wang Y; Bu J; Kong X; Sun D
Oncol Res; 2018 Apr; 26(3):385-400. PubMed ID: 28653608
[TBL] [Abstract][Full Text] [Related]
13. SOX4: The unappreciated oncogene.
Moreno CS
Semin Cancer Biol; 2020 Dec; 67(Pt 1):57-64. PubMed ID: 31445218
[TBL] [Abstract][Full Text] [Related]
14. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.
Tiwari N; Tiwari VK; Waldmeier L; Balwierz PJ; Arnold P; Pachkov M; Meyer-Schaller N; Schübeler D; van Nimwegen E; Christofori G
Cancer Cell; 2013 Jun; 23(6):768-83. PubMed ID: 23764001
[TBL] [Abstract][Full Text] [Related]
15. The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism.
Bin C; Xiaofeng H; Wanzi X
Exp Lung Res; 2018 Aug; 44(6):280-287. PubMed ID: 30475081
[TBL] [Abstract][Full Text] [Related]
16. The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe?
Vervoort SJ; van Boxtel R; Coffer PJ
Oncogene; 2013 Jul; 32(29):3397-409. PubMed ID: 23246969
[TBL] [Abstract][Full Text] [Related]
17. ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.
Wang L; Li Y; Yang X; Yuan H; Li X; Qi M; Chang YW; Wang C; Fu W; Yang M; Zhang J; Han B
Prostate; 2014 May; 74(6):647-58. PubMed ID: 24435928
[TBL] [Abstract][Full Text] [Related]
18. Upregulated Expression of SOX4 Is Associated with Tumor Growth and Metastasis in Nasopharyngeal Carcinoma.
Shi S; Cao X; Gu M; You B; Shan Y; You Y
Dis Markers; 2015; 2015():658141. PubMed ID: 26578818
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-212 acts as a tumor-suppressor in colorectal carcinoma through targeting SOX4.
Mou TY; Zhang RR; Wang YN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10751-10760. PubMed ID: 31858542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]